Brigham and Women's Hospital investigators link very high lipoprotein(a) with a higher 30-year risk of major cardiovascular ...

Lipoprotein(a) levels greater 30 mg/dL linked to increased 30-year risk for major CV events and coronary heart disease.

A nearly 30-year study shows a strong long-term association between very high lipoprotein(a) levels and cardiovascular ...

Very high Lp(a) also correlated with higher risks of ischemic stroke and cardiovascular mortality in the Women’s Health Study ...

Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...

Comparing extremes of the spectrum, multivariable analyses generally showed significantly higher risks for patients with high lipoprotein (a) levels versus low levels (>120 mg/dL vs <10 mg/dL) or when ...

As part of "heart health month," we're looking at lipoprotein (a). For decades, doctors have encouraged patients to monitor their cholesterol levels, with studies showing that heart disease risk ...

At the 44th Annual JP Morgan Healthcare conference 2026, Eli Lilly highlighted lepodisiran and muvalaplin as the key drugs in ...

A new study finds that elevated levels of Lp(a) may increase the risk of death from cardiovascular disease in some patie ...

Low-density lipoprotein, known as LDL, is a complex structure with several components that allow cholesterol to circulate in the bloodstream, a watery environment. LDL is the primary mechanism used to ...